The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
VASEN, H., WATSON, P., MECKLIN, J., & LYNCH, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70510-x · Cited by 2,519
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
Vasen, H. F. A., Mecklin, J. P., Meera Khan, P., & Lynch, H. T. (1991) · Diseases of the Colon & Rectum · doi:10.1007/bf02053699 · Cited by 2,147
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Burnside, R. D. (2015) · Cytogenetic and Genome Research · doi:10.1159/000438708 · Cited by 1,946
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Very high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,445
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408
Self-citationGerm-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Kloos (Chair), R. T., Eng, C., Evans, D. B., Francis, G. L., Gagel, R. F., Gharib, H., Moley, J. F., Pacini, F., Ringel, M. D., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2008.0403 · Cited by 1,357
Cancer risk in mutation carriers of DNA-mismatch-repair genes
Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltom�ki, P., Mecklin, J.-P., & J�rvinen, H. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l · Cited by 1,278
Aaltonen, L. A., Salovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomäki, P., Chadwick, R. B., Kääriäinen, H., Eskelinen, M., Järvinen, H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382101 · Cited by 1,152
Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic Criteria
Roach, E. S., Gomez, M. R., & Northrup, H. (1998) · Journal of Child Neurology · doi:10.1177/088307389801301206 · Cited by 1,081
Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome
Kimonis, V. E., Goldstein, A. M., Pastakia, B., Yang, M. L., Kase, R., DiGiovanna, J. J., Bale, A. E., & Bale, S. J. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970331)69:3<299::aid-ajmg16>3.0.co;2-m · Cited by 1,010
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318787 · Cited by 986
Walsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A. M., Roeb, W., Agnew, K. J., Stray, S. M., Wickramanayake, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115052108 · Cited by 933
Mutations in the SMAD4/DPC4 Gene in Juvenile Polyposis
Howe, J. R., Roth, S., Ringold, J. C., Summers, R. W., Järvinen, H. J., Sistonen, P., Tomlinson, I. P. M., Houlston, R. S., Bevan, S., Mitros, F. A., et al. (1998) · Science · doi:10.1126/science.280.5366.1086 · Cited by 907
Neumann, H. P. H. (2004) · JAMA · doi:10.1001/jama.292.8.943 · Cited by 893
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
Tan, M.-H., Mester, J. L., Ngeow, J., Rybicki, L. A., Orloff, M. S., & Eng, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2283 · Cited by 892
Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Clendenning, M., Sotamaa, K., Prior, T., Westman, J. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5950 · Cited by 876
Self-citationCastro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., Mahmud, N., Dadaev, T., Govindasami, K., Guy, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.1882 · Cited by 850
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826
Stratakis, C. A., Kirschner, L. S., & Carney, J. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4041 · Cited by 826
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
Gallione, C. J., Repetto, G. M., Legius, E., Rustgi, A. K., Schelley, S. L., Tejpar, S., Mitchell, G., Drouin, É., Westermann, C. J., & Marchuk, D. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15732-2 · Cited by 756
(2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.189 · Cited by 751
Genetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P. A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj465 · Cited by 680
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Ewing, C. M., Ray, A. M., Lange, E. M., Zuhlke, K. A., Robbins, C. M., Tembe, W. D., Wiley, K. E., Isaacs, S. D., Johng, D., Wang, Y., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110000 · Cited by 658
Pilarski, R., Burt, R., Kohlman, W., Pho, L., Shannon, K. M., & Swisher, E. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt277 · Cited by 654
Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., & Brody, L. C. (1995) · Nature Genetics · doi:10.1038/ng1095-198 · Cited by 647
Toro, J. R., Nickerson, M. L., Wei, M.-H., Warren, M. B., Glenn, G. M., Turner, M. L., Stewart, L., Duray, P., Tourre, O., Sharma, N., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376435 · Cited by 634
Janeway, K. A., Kim, S. Y., Lodish, M., Nosé, V., Rustin, P., Gaal, J., Dahia, P. L. M., Liegl, B., Ball, E. R., Raygada, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009199108 · Cited by 628
Hereditary Prostate Cancer: Epidemiologic and Clinical Features
Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., & Walsh, P. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35617-3 · Cited by 612
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Gonzalez, K. D., Noltner, K. A., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Nguyen, V. Q., Han, J. H., Lowstuter, K., Longmate, J., Sommer, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6959 · Cited by 609
Gonzalez-Angulo, A. M., Timms, K. M., Liu, S., Chen, H., Litton, J. K., Potter, J., Lanchbury, J. S., Stemke-Hale, K., Hennessy, B. T., Arun, B. K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2560 · Cited by 573
Will the real Cowden syndrome please stand up: revised diagnostic criteria
Eng, C. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.828 · Cited by 566
The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations
Senter, L., Clendenning, M., Sotamaa, K., Hampel, H., Green, J., Potter, J. D., Lindblom, A., Lagerstedt, K., Thibodeau, S. N., Lindor, N. M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.026 · Cited by 550
Self-citationFitzgerald, R. C., Hardwick, R., Huntsman, D., Carneiro, F., Guilford, P., Blair, V., Chung, D. C., Norton, J., Ragunath, K., Van Krieken, J. H., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.074237 · Cited by 542
Population-Based Molecular Detection of Hereditary Nonpolyposis Colorectal Cancer
Salovaara, R., Loukola, A., Kristo, P., Kääriäinen, H., Ahtola, H., Eskelinen, M., Härkönen, N., Julkunen, R., Kangas, E., Ojala, S., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2193 · Cited by 516
Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
Bishop, D. T. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.894 · Cited by 509
Witkowski, L., Carrot-Zhang, J., Albrecht, S., Fahiminiya, S., Hamel, N., Tomiak, E., Grynspan, D., Saloustros, E., Nadaf, J., Rivera, B., et al. (2014) · Nature Genetics · doi:10.1038/ng.2931 · Cited by 501
Novel mutations of the MET proto-oncogene in papillary renal carcinomas
Schmidt, L., Junker, K., Nakaigawa, N., Kinjerski, T., Weirich, G., Miller, M., Lubensky, I., Neumann, H. P., Brauch, H., Decker, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202547 · Cited by 497
ATM Mutations in Patients with Hereditary Pancreatic Cancer
Roberts, N. J., Jiao, Y., Yu, J., Kopelovich, L., Petersen, G. M., Bondy, M. L., Gallinger, S., Schwartz, A. G., Syngal, S., Cote, M. L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0194 · Cited by 491
BRCA2 germline mutations in familial pancreatic carcinoma
Hahn, S. A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J. A., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.214 · Cited by 480
Palomaki, G. E., McClain, M. R., Melillo, S., Hampel, H. L., & Thibodeau, S. N. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e31818fa2db · Cited by 467
Self-citationJuvenile polyposis–a precancerous condition
JASS, J. R., WILLIAMS, C. B., BUSSEY, H. J. R., & MORSON, B. C. (1988) · Histopathology · doi:10.1111/j.1365-2559.1988.tb02093.x · Cited by 459
Bertherat, J., Horvath, A., Groussin, L., Grabar, S., Boikos, S., Cazabat, L., Libe, R., René-Corail, F., Stergiopoulos, S., Bourdeau, I., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2333 · Cited by 449
Murphy, K. M., Brune, K. A., Griffin, C. A., Sollenberger, J. E., Petersen, G. M., Bansal, R. K., Hruban, R. H., & Kern, S. E. (2002) · PubMed · Cited by 435
Goldstein, A. M., Chan, M., Harland, M., Gillanders, E. M., Hayward, N. K., Avril, M.-F., Azizi, E., Bianchi-Scarra, G., Bishop, D. T., Bressac-de Paillerets, B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0494 · Cited by 426
Cancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
Liede, A., Karlan, B. Y., & Narod, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 407
Cancer Risk in Hereditary Nonpolyposis Colorectal Cancer Syndrome: Later Age of Onset
HAMPEL, H., STEPHENS, J., PUKKALA, E., SANKILA, R., AALTONEN, L., MECKLIN, J., & DELACHAPELLE, A. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.011 · Cited by 407
Self-citationU.S. Preventive Services Task Force* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00011 · Cited by 405
Nieuwenhuis, M. H., & Vasen, H. F. A. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.004 · Cited by 387
Ramos, P., Karnezis, A. N., Craig, D. W., Sekulic, A., Russell, M. L., Hendricks, W. P. D., Corneveaux, J. J., Barrett, M. T., Shumansky, K., Yang, Y., et al. (2014) · Nature Genetics · doi:10.1038/ng.2928 · Cited by 387
Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors
Eaton, K. W., Tooke, L. S., Wainwright, L. M., Judkins, A. R., & Biegel, J. A. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22831 · Cited by 384
High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome
Bubien, V., Bonnet, F., Brouste, V., Hoppe, S., Barouk-Simonet, E., David, A., Edery, P., Bottani, A., Layet, V., Caron, O., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101339 · Cited by 376
Multiple endocrine neoplasia type 1.
Pannett, A. A., & Thakker, R. V. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060449 · Cited by 345
Sensitivity and predictive value of criteria for p53 germline mutation screening
CHOMPRET, A., ABEL, A., STOPPA-LYONNET, D., BRUGIÈRES, L., PAGÈS, S., FEUNTEUN, J., & BONAÏTI-PELLIÉ, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.1.43 · Cited by 341
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
Wells, S. A., Pacini, F., Robinson, B. G., & Santoro, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1204 · Cited by 338
Alam, N. A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg148 · Cited by 324
Wei, M.-H., Toure, O., Glenn, G. M., Pithukpakorn, M., Neckers, L., Stolle, C., Choyke, P., Grubb, R., Middelton, L., Turner, M. L., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033506 · Cited by 313
Concise Handbook of Familial Cancer Susceptibility Syndromes - Second Edition
Lindor, N. M., McMaster, M. L., Lindor, C. J., & Greene, M. H. (2008) · JNCI Monographs · doi:10.1093/jncimonographs/lgn001 · Cited by 307
Ruijs, M. W. G., Verhoef, S., Rookus, M. A., Pruntel, R., van der Hout, A. H., Hogervorst, F. B. L., Kluijt, I., Sijmons, R. H., Aalfs, C. M., Wagner, A., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.073429 · Cited by 305
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer
Neuhausen, S., Gilewski, T., Norton, L., Tran, T., McGuire, P., Swensen, J., Hampel, H., Borgen, P., Brown, K., Skolnick, M., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-126 · Cited by 304
Self-citationDiagnosis of Tuberous Sclerosis Complex
Roach, E. S., & Sparagana, S. P. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190090301 · Cited by 281
ACOG Practice Bulletin No. 103: Hereditary Breast and Ovarian Cancer Syndrome
(2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181a106d4 · Cited by 281
PALB2 mutations in European familial pancreatic cancer families
Slater, E., Langer, P., Niemczyk, E., Strauch, K., Butler, J., Habbe, N., Neoptolemos, J., Greenhalf, W., & Bartsch, D. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01425.x · Cited by 278
Jaeger, E., Leedham, S., Lewis, A., Segditsas, S., Becker, M., Cuadrado, P. R., Davis, H., Kaur, K., Heinimann, K., Howarth, K., et al. (2012) · Nature Genetics · doi:10.1038/ng.2263 · Cited by 276
The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Brune, K., de Andrade, M., Goggins, M., Rothenmund, H., Gallinger, S., Klein, A., Petersen, G. M., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0783 · Cited by 275
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
Young, Sr., Pilarski, R. T., Donenberg, T., Shapiro, C., Hammond, L. S., Miller, J., Brooks, K. A., Cohen, S., Tenenholz, B., DeSai, D., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-86 · Cited by 273
Heald, B., Mester, J., Rybicki, L., Orloff, M. S., Burke, C. A., & Eng, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.061 · Cited by 271
Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors
Varley, J. M., McGown, G., Thorncroft, M., James, L. A., Margison, G. P., Forster, G., Evans, D. G. R., Harris, M., Kelsey, A. M., & Birch, J. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302575 · Cited by 266
HARACH, H. R., WILLIAMS, G. T., & WILLIAMS, E. D. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb01374.x · Cited by 259
Prevalence and Phenotypes of APC and MUTYH Mutations in Patients With Multiple Colorectal Adenomas
Grover, S., Kastrinos, F., Steyerberg, E. W., Cook, E. F., Dewanwala, A., Burbidge, L. A., Wenstrup, R. J., & Syngal, S. (2012) · JAMA · doi:10.1001/jama.2012.8780 · Cited by 246
Aretz, S., Stienen, D., Uhlhaas, S., Stolte, M., Entius, M. M., Loff, S., Back, W., Kaufmann, A., Keller, K.-M., Blaas, S. H., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.052506 · Cited by 242
Sarcomas in TP53 germline mutation carriers: A review of the IARC TP53 database
Ognjanovic, S., Olivier, M., Bergemann, T. L., & Hainaut, P. (2012) · Cancer · doi:10.1002/cncr.26390 · Cited by 238
Family history-taking in community family practice: Implications for genetic screening
Acheson, L. S., Wiesner, G. L., Zyzanski, S. J., Goodwin, M. A., & Stange, K. C. (2000) · Genetics in Medicine · doi:10.1097/00125817-200005000-00004 · Cited by 236
Self-citationRisk of Soft Tissue Sarcomas by Individual Subtype in Survivors of Hereditary Retinoblastoma
Kleinerman, R. A., Tucker, M. A., Abramson, D. H., Seddon, J. M., Tarone, R. E., & Fraumeni, J. F. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk002 · Cited by 234
Lal, G., Liu, G., Schmocker, B., Kaurah, P., Özçelik, H., Narod, S. A., Redston, M. S., & Gallinger, S. (2000) · PubMed · Cited by 231
Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families
Bougeard, G., Sesboüé, R., Baert-Desurmont, S., Vasseur, S., Martin, C., Tinat, J., Brugières, L., Chompret, A., Paillerets, B. B.-D., Stoppa-Lyonnet, D., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.057570 · Cited by 230
Germline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer Risk
Hwang, S.-J., Lozano, G., Amos, C. I., & Strong, L. C. (2003) · The American Journal of Human Genetics · doi:10.1086/374567 · Cited by 229
Zhou, X.-P., Marsh, D. J., Morrison, C. D., Chaudhury, A. R., Maxwell, M., Reifenberger, G., & Eng, C. (2003) · The American Journal of Human Genetics · doi:10.1086/379382 · Cited by 229
Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway.
Lipton, L. R., Halford, S. E. R., Johnson, V., Novelli, M. R., Jones, A., Cummings, C., Barclay, E., Sieber, O. M., Sadat, A. T. E., Bisgaard, M.-L., et al. (2003) · PubMed · Cited by 229
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients
Özcelik, H., Schmocker, B., Nicola, N. D., Shi, X.-H., Langer, B., Moore, M., Taylor, B. R., Narod, S. A., Darlington, G., Andrulis, I. L., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-17 · Cited by 225
Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor
Bourdeaut, F., Lequin, D., Brugières, L., Reynaud, S., Dufour, C., Doz, F., André, N., Stephan, J.-L., Pérel, Y., Oberlin, O., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1795 · Cited by 224
Clinical Implications of the Colorectal Cancer Risk Associated With MUTYH Mutation
Lubbe, S. J., Di Bernardo, M. C., Chandler, I. P., & Houlston, R. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6853 · Cited by 224
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.
Jóhannesdóttir, G., Guðmundsson, J., Bergþorsson, J. Þ., Arason, A., Agnarsson, B. A., Eiríksdóttir, G., Johannsson, O. T., Borg, Å., Ingvarsson, S., Easton, D. F., et al. (1996) · PubMed · Cited by 223
Colorectal neoplasia in juvenile polyposis or juvenile polyps.
Giardiello, F. M., Hamilton, S. R., Kern, S. E., Offerhaus, G. J., Green, P. A., Celano, P., Krush, A. J., & Booker, S. V. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.8.971 · Cited by 222
Wang, L., Baudhuin, L. M., Boardman, L. A., Steenblock, K. J., Petersen, G. M., Halling, K. C., French, A. J., Johnson, R. A., Burgart, L. J., Rabe, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.070 · Cited by 218
Lifetime Risk of Melanoma in CDKN2A Mutation Carriers in a Population-Based Sample
Begg, C. B., Orlow, I., Hummer, A. J., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Anton-Culver, H., Zanetti, R., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji312 · Cited by 213
BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma
Ferrone, C. R., Levine, D. A., Tang, L. H., Allen, P. J., Jarnagin, W., Brennan, M. F., Offit, K., & Robson, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5546 · Cited by 206
International Consortium for Prostate Cancer Genetics, Xu, J., Lange, E. M., Lu, L., Zheng, S. L., Wang, Z., Thibodeau, S. N., Cannon-Albright, L. A., Teerlink, C. C., Camp, N. J., et al. (2013) · Human Genetics · doi:10.1007/s00439-012-1229-4 · Cited by 201
Neumann, H. P. H., Erlic, Z., Boedeker, C. C., Rybicki, L. A., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Bauters, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4057 · Cited by 194
Groussin, L., Kirschner, L. S., Vincent-Dejean, C., Perlemoine, K., Jullian, E., Delemer, B., Zacharieva, S., Pignatelli, D., Carney, J. A., Luton, J. P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/344579 · Cited by 192
Tischkowitz, M. D., Sabbaghian, N., Hamel, N., Borgida, A., Rosner, C., Taherian, N., Srivastava, A., Holter, S., Rothenmund, H., Ghadirian, P., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.055 · Cited by 189
Juvenile Polyposis Syndrome: A Study of Genotype, Phenotype, and Long-term Outcome
Latchford, A. R., Neale, K., Phillips, R. K. S., & Clark, S. K. (2012) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e31826278b3 · Cited by 188
NEUMANN, H. P. H., BENDER, B. U., BERGER, D. P., LAUBENBERGER, J., SCHULTZE-SEEMANN, W., WETTERAUER, U., FERSTL, F. J., HERBST, E. W., SCHWARZKOPF, G., HES, F. J., et al. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62509-6 · Cited by 183
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
Collaborators, T. I. A. E., Mitra, A., Fisher, C., Foster, C. S., Jameson, C., Barbachanno, Y., Bartlett, J., Bancroft, E., Doherty, R., Kote-Jarai, Z., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604132 · Cited by 173
Constitutional mismatch repair-deficiency syndrome
Wimmer, K., & Kratz, C. P. (2010) · Haematologica · doi:10.3324/haematol.2009.021626 · Cited by 172
Jenkins, M. A., Baglietto, L., Dowty, J. G., Van Vliet, C. M., Smith, L., Mead, L. J., Macrae, F. A., St. John, D. J. B., Jass, J. R., Giles, G. G., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.01.002 · Cited by 171
Patterns of risk of hereditary retinoblastoma and applications to genetic counselling
Draper, G., Sanders, B., Brownbill, P., & Hawkins, M. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.244 · Cited by 170
Groussin, L., Jullian, E., Perlemoine, K., Louvel, A., Leheup, B., Luton, J. P., Bertagna, X., & Bertherat, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020592 · Cited by 169
Hepatoblastoma and APC gene mutation in familial adenomatous polyposis.
Giardiello, F. M., Petersen, G. M., Brensinger, J. D., Luce, M. C., Cayouette, M. C., Bacon, J., Booker, S. V., & Hamilton, S. R. (1996) · Gut · doi:10.1136/gut.39.6.867 · Cited by 169
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases
Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168
Pilarski, R., Stephens, J. A., Noss, R., Fisher, J. L., & Prior, T. W. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2011.088807 · Cited by 165
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria
Hampel, H., Sweet, K., Westman, J. A., Offit, K., & Eng, C. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.010918 · Cited by 158
Self-citationCentral nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease
Richard, S., David, P., Marsot-Dupuch, K., Giraud, S., Béroud, C., & Resche, F. (2000) · Neurosurgical Review · doi:10.1007/s101430050024 · Cited by 153
Alam, N., Olpin, S. E., & Leigh, I. M. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06678.x · Cited by 151
Balaguer, F., Castellvı́-Bel, S., Castells, A., Andreu, M. G., Muñoz, J., Gisbert, J. P., Llor, X., Jover, R., de Cid, R., Gonzalo, V., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.025 · Cited by 151
A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
Karlsson, R., Aly, M., Clements, M., Zheng, L. S., Adolfsson, J., Xu, J., Grönberg, H., & Wiklund, F. E. (2012) · European Urology · doi:10.1016/j.eururo.2012.07.027 · Cited by 150
Miller, C. E., Krautscheid, P., Baldwin, E. E., Tvrdik, T., Openshaw, A., Hart, K., & LaGrave, D. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36453 · Cited by 149
Gardie, B., Remenieras, A., Kattygnarath, D., Bombled, J., Lefèvre, S.-H., Perrier-Trudova, V., Rustin, P., Barrois, M., Slama, A., Avril, M., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.085068 · Cited by 148
Second primary tumors in patients with retinoblastoma a review of the literature
Moll, A. C., Imhof, S. M., Bouter, L. M., & Tan, K. E. W. P. (1997) · Ophthalmic Genetics · doi:10.3109/13816819709057880 · Cited by 147
The duration of ambulatory visits to physicians.
Blumenthal, D., Causino, N., Chang, Y., Culpepper, L., Marder, W. D., Saglam, D., Stafford, R. S., & Starfield, B. H. (1999) · PubMed · Cited by 144
Germline BRCA1 185delAG mutations in Jewish women with breast cancer
Offit, K., McGuire, P., Schluger, A. E., Hampel, H., Brown, K., Gilewski, T. A., Norton, L., Swensen, J. J., Neuhausen, S. L., Skolnick, M. H., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91484-1 · Cited by 144
Self-citation(2001) · Gastroenterology · doi:10.1053/gast.2001.25580 · Cited by 137
Pheochromocytoma and paraganglioma syndromes: genetics and management update
Lefebvre, M., & Foulkes, W. D. (2013) · Current Oncology · doi:10.3747/co.21.1579 · Cited by 125
Fostira, F., Tsitlaidou, M., PAPADIMITRIOU, C. A., Pertesi, M., Timotheadou, E. T., Stavropoulou, A. V., Glentis, S., Bournakis, E., Bobos, M., Pectasides, D. G., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2021-9 · Cited by 110
Adverse Events in Cancer Genetic Testing
Brierley, K. L., Blouch, E. L., Cogswell, W. A., Homer, J. P., Pencarinha, D., Stanislaw, C. L., & Matloff, E. T. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182609490 · Cited by 106
Bensend, T. A., Veach, P. M., & Niendorf, K. B. (2013) · Journal of Genetic Counseling · doi:10.1007/s10897-013-9605-3 · Cited by 102
Weitzel, J. N., Lagos, V. I., Herzog, J., Judkins, T., Hendrickson, B. C., Ho, J. S., Ricker, C. N., Lowstuter, K. J., Blazer, K. R., Tomlinson, G. E., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0198 · Cited by 100
Family history: the three-generation pedigree.
Wattendorf, D. J., & Hadley, D. W. (2005) · PubMed · Cited by 97
The tuberous sclerosis complex: a comprehensive review
Weiner, D., Ewalt, D. H., Roach, E. S., & Hensle, T. W. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00239-7 · Cited by 91
SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors
Oudijk, L., Gaal, J., Korpershoek, E., van Nederveen, F. H., Kelly, L., Schiavon, G., Verweij, J., Mathijssen, R. H. J., den Bakker, M. A., Oldenburg, R. A., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.186 · Cited by 90
Cao, X., Eu, K. W., Kumarasinghe, P. M., Li, H. H., Loi, C., & Cheah, P. Y. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.034827 · Cited by 88
Germline mutations in the vhl gene in patients presenting with phaeochromocytomas
van der Harst, E., de Krijger, R. R., Dinjens, W. N. M., Weeks, L., Bonjer, H. J., Bruining, H. A., Lamberts, S. W. J., & Koper, J. W. (1998) · International Journal of Cancer · Cited by 87
Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM).
Cannon‐Albright, L., Meyer, L. J., Goldgar, D. E., Lewis, C. M., McWhorter, W. P., Jost, M., Harrison, D., Anderson, D. E., Zone, J. J., & Skolnick, M. H. (1994) · PubMed · Cited by 86
Badenhop, R. F., Jansen, J. C., Fagan, P. A., Lord, R. S. A., Wang, Z. G., Foster, W. J., & Schofield, P. R. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.011551 · Cited by 86
Brauch, H. B., Hoeppner, W., Jähnig, H., Wöhl, T., Engelhardt, D., Spelsberg, F. W., & Ritter, M. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4454 · Cited by 84
Lynch Syndrome and MYH-Associated Polyposis
Goodenberger, M. L., & Lindor, N. M. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318206489c · Cited by 74
Germline Fumarate Hydratase Mutations in Families with Multiple Cutaneous and Uterine Leiomyomata
Martı́nez-Mir, A., Gläser, B., Chuang, G. S., Horev, L., Waldman, A., Engler, D. E., Gordon, D., Spelman, L. J., Hatzibougias, I., Green, J., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12499.x · Cited by 72
Seevaratnam, R., Coburn, N. G., Cardoso, R., Dixon, M. E. B., Bocicariu, A., & Helyer, L. K. (2011) · Gastric Cancer · doi:10.1007/s10120-011-0116-3 · Cited by 71
Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes
Ponti, G., Pellacani, G., Seidenari, S., Pollio, A., Muscatello, U., & Tomasi, A. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.07.001 · Cited by 71
Evolution of Cardiac Rhabdomyoma in Tuberous Sclerosis Complex
DiMario, F. J., Diana, D. J., Leopold, H. B., & Chameides, L. (1996) · Clinical Pediatrics · doi:10.1177/000992289603501202 · Cited by 58
American Founder Mutation for Attenuated Familial Adenomatous Polyposis
Neklason, D. W., Stevens, J., Boucher, K. M., Kerber, R. A., Matsunami, N., Barlow, J., Mineau, G. P., Leppert, M., & Burt, R. W. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.09.017 · Cited by 57
Cheah, P. Y., Wong, Y. H., Chau, Y. P., Loi, C. T., Lim, K. H., Lim, J. F., Koh, P. K., & Eu, K. W. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.542 · Cited by 55
Keck, K. J., & Howe, J. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-28103-2_6 · Cited by 51
Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families
Slater, E. P., Langer, P., Fendrich, V., Habbe, N., Chaloupka, B., Matthäi, E., Sina‐Frey, M., Hahn, S. A., & Bartsch, D. K. (2010) · Familial Cancer · doi:10.1007/s10689-010-9329-6 · Cited by 49
When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?
Erlic, Z., & Neumann, H. P. H. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03480.x · Cited by 45
Bonadona, V., Bonaïti, B., Olschwang, S., Grandjouan, S., Wang, Q., Bonaïti‐Pellié, C., & Lasset, C. (2011) · HAL · Cited by 36
Richards, M. L. (2008) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2008.08.002 · Cited by 34
Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma‐prone families
Bartsch, D., Langer, P., Habbe, N., Matthäi, E., Chaloupka, B., Sina‐Frey, M., Hahn, S. A., & Slater, E. P. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01352.x · Cited by 28
Biochemistry, genetics and therapy of malignant pheochromocytomas
Mannelli, M. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.02.009 · Cited by 4
Cited by
Mandelker, D., Zhang, L., Kemel, Y., Stadler, Z. K., Joseph, V., Zehir, A., Pradhan, N., Arnold, A., Walsh, M. F., Li, Y., et al. (2017) · JAMA · doi:10.1001/jama.2017.11137 · Cited by 511
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
Konstantinopoulos, P. A., Norquist, B., Lacchetti, C., Armstrong, D., Grisham, R. N., Goodfellow, P. J., Kohn, E. C., Levine, D. A., Liu, J. F., Lu, K. H., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02960 · Cited by 381
Strosberg, J. R., Halfdanarson, T. R., Bellizzi, A. M., Chan, J. A., Dillon, J. S., Heaney, A. P., Kunz, P. L., O’Dorisio, T. M., Salem, R., Segelov, E., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000850 · Cited by 373
Nicolosi, P., Ledet, E., Yang, S., Michalski, S., Freschi, B., O’Leary, E., Esplin, E. D., Nussbaum, R. L., & Sartor, O. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.6760 · Cited by 365
Samadder, N. J., Riegert-Johnson, D., Boardman, L., Rhodes, D., Wick, M., Okuno, S., Kunze, K. L., Golafshar, M., Uson, P. L. S., Mountjoy, L., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.6252 · Cited by 304
Metadata
- Authors
- Hampel, H., Bennett, R. L., Buchanan, A., Pearlman, R., & Wiesner, G. L.
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 17
- Issue
- 1
- Pages
- 70-87
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2084988326
- Cited by
- 587
- References
- 151
- FWCI
- 21.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.